Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00639535
What this trial is testing

Study Comparing the PET Scan and MRI in Identifying Breast Malignancies in Women With Breast Abnormalities

Who this might be right for
Breast Disease
State University of New York - Upstate Medical University 56
Not applicableStudy completedNCT05730855
What this trial is testing

Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions

Who this might be right for
Potentially Malignant LesionsOral Lichen PlanusLeukoplakia, Oral
Fayoum University 45
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT02372708
What this trial is testing

Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy

Who this might be right for
Melanoma
Chinese PLA General Hospital 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Not applicableActive Not RecruitingNCT04174391
What this trial is testing

Lifestyles and Breast Cancer

Who this might be right for
Malignant Tumor of Breast
University of Navarra 766
Early research (Phase 1)Study completedNCT01021059
What this trial is testing

A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer

Who this might be right for
MelanomaCarcinoma, Renal Cell
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT00287196
What this trial is testing

Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

Who this might be right for
Malignant MelanomaLymph Node Disease
Trans Tasman Radiation Oncology Group 250
Early research (Phase 1)UnknownNCT04763083
What this trial is testing

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4 more
NovalGen Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00665470
What this trial is testing

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Who this might be right for
Skin CancerMetastatic Melanoma
National Cancer Institute (NCI) 10
Not applicableLooking for participantsNCT05853783
What this trial is testing

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

Who this might be right for
Mouth Diseases
Proteocyte Diagnostics Inc. 180
Testing effectiveness (Phase 2)Study completedNCT01037790
What this trial is testing

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Who this might be right for
Adult Solid TumorAdenocarcinoma of the ColonAdenocarcinoma of the Rectum+36 more
Abramson Cancer Center at Penn Medicine 304
Early research (Phase 1)Looking for participantsNCT03113643
What this trial is testing

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeBlastic Plasmacytoid Dendritic Cell Neoplasm
Dana-Farber Cancer Institute 72
Early research (Phase 1)Study completedNCT03158935
What this trial is testing

The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

Who this might be right for
Advanced Ovarian CancerMalignant Melanoma
University Health Network, Toronto 8
Early research (Phase 1)Study completedNCT00005617
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma

Who this might be right for
Melanoma
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06422455
What this trial is testing

Access to Genetic Testing in Underserved Patients With Cancer

Who this might be right for
Breast CarcinomaMale Breast CarcinomaMalignant Solid Neoplasm+5 more
University of Southern California 800
Early research (Phase 1)Ended earlyNCT00003060
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Louisiana State University Health Sciences Center Shreveport 6
Testing effectiveness (Phase 2)Study completedNCT00397982
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
National Cancer Institute (NCI) 17
Not applicableEnrolling By InvitationNCT05486520
What this trial is testing

Low-field MRI for Breast Cancer Screening

Who this might be right for
Breast BenignMalignant Neoplasm of BreastBreast Malignant Tumor
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT04216524
What this trial is testing

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm
M.D. Anderson Cancer Center 40
Next Page